Transmeta's revenues continue to grow - not hard when you start at zip - while its loss widened slightly during the first three months of fiscal 2001.

So, revenue for the period, which ended on 31 March, reached $18.6 million, up 50.2 per cent on the previous quarter's figure of $12.4 million. Neither is a vast figure in chip industry terms, but it's an increase the company can be proud of given the depressed state of the market.

The cost of Transmeta's operations took the company into the red to the tune of $13.2 million (10 cents a share), but other charges take it to $22.67 million (18 cents a share). Q1 2000's comparable figures were $16.7 million (56 cents a share) and $20 million (67 cents a share), respectively.

Looking ahead, the company's new president and CEO, Mark Allen, said Transmeta will roll-out its Crusoe CPU in the US and Europe later this year. Not in time for Q2, it seems, which the company reckons will realise revenues of just over the $18.6 million it recorded this past quarter. Q2 gross margin will match Q1's: 44 per cent. Spending on R&D will match the first quarter too, coming in at $26.1 million. In short, don't expect much of a quarter-on-quarter change. ®